Cardinal Health Reports $67.5 Billion First-Quarter Revenue, Raises Fiscal 2027 Outlook
Cardinal Health completed a $500 million share repurchase and entered into a binding letter of intent to renew pharmaceutical distribution agreements with CVS Health.
On Nov. 5, Dublin, Ohio-based Cardinal Health reported first-quarter revenue of $67.5 billion, an increase of 5% from the first quarter of fiscal year 2026. Cardinal Health also furnished the news release and results for the quarter ended Sept. 30, 2026, in an SEC Form 8-K filing.
For the first quarter, the company reported GAAP operating earnings of $753 million, up 13% from the year-ago period, and GAAP diluted earnings per share of $2.38, an increase of 27%. On a non-GAAP basis, operating earnings grew 17% to $1.0 billion and diluted earnings per share rose 28% to $3.26.
Cardinal Health completed a $500 million share repurchase during the first quarter. Following the results, company management raised its fiscal 2027 guidance for non-GAAP diluted earnings per share to between $12.80 and $13.00, up from an earlier range of $12.40 to $12.60.
In its report, Cardinal Health also announced that it entered into a binding letter of intent to renew its pharmaceutical distribution agreements with CVS Health. The earnings release did not state the financial terms of the renewal agreement.
Cardinal Health announced that it will host a webcast at 8:30 a.m. to discuss first-quarter results.
How we know this
The sources and records behind this story, with the facts they support.
Supporting evidence (7)
On Nov. 5, Dublin, Ohio-based Cardinal Health reported first-quarter revenue of $67.5 billion, an increase of 5% from the first quarter of fiscal year 2026.
Read supporting passage
DUBLIN, Ohio, Nov. 5, 2026 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today reported first quarter fiscal year 2027 revenues of $67.5 billion, an increase of 5% from the first quarter of fiscal year 2026.
For the first quarter, the company reported GAAP operating earnings of $753 million, up 13% from the year-ago period, and GAAP diluted earnings per share of $2.38, an increase of 27%.
Read supporting passage
First quarter GAAP operating earnings increased 13% to $753 million and GAAP diluted earnings per share (EPS) increased 27% to $2.38.
On a non-GAAP basis, operating earnings grew 17% to $1.0 billion and diluted earnings per share rose 28% to $3.26.
Read supporting passage
First quarter non-GAAP operating earnings increased 17% to $1.0 billion. Non-GAAP diluted EPS increased 28% to $3.26, reflecting the increase in non-GAAP operating earnings, a lower share count, and a lower effective tax rate.
Cardinal Health completed a $500 million share repurchase during the first quarter.
Read supporting passage
Cardinal Health completes $500 million share repurchase program in first quarter
Following the results, company management raised its fiscal 2027 guidance for non-GAAP diluted earnings per share to between $12.80 and $13.00, up from an earlier range of $12.40 to $12.60.
Read supporting passage
Cardinal Health is raising its fiscal year 2027 guidance for non-GAAP diluted EPS to $12.80 to $13.00, from the previous range of $12.40 to $12.60.
In its report, Cardinal Health also announced that it entered into a binding letter of intent to renew its pharmaceutical distribution agreements with CVS Health.
Read supporting passage
Cardinal Health entered into a binding letter of intent to renew its pharmaceutical distribution agreements with CVS Health, reinforcing a long-standing strategic relationship and enabling continued volume growth within the Pharmaceutical and Specialty Solutions segment
Cardinal Health announced that it will host a webcast at 8:30 a.m. to discuss first-quarter results.
Read supporting passage
Cardinal Health will host a webcast today at 8:30 a.m. ET to discuss first quarter results.
Cardinal Health 8-K Items 2.02/7.01 — Q1 FY2027 results, filed Nov. 5, 2026
Supporting evidence (1)
Cardinal Health also furnished the news release and results for the quarter ended Sept. 30, 2026, in an SEC Form 8-K filing.
Read supporting passage
Cardinal Health 8-K Items 2.02/7.01 — Q1 FY2027 results, filed Nov. 5, 2026 Primary SEC filing. Ex. 99.1 is the news release for quarter ended Sept. 30, 2026.